A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Brigham And Womens Hospital, Boston, Massachusetts, United States

Duke University, Durham, North Carolina, United States

Local Institution - 0007, Camperdown, New South Wales, Australia

Local Institution - 0008, Brisbane, Queensland, Australia

Local Institution - 0013, Clayton, Victoria, Australia

Local Institution - 0040, Salvador, Estado de Bahia, Brazil

Local Institution - 0039, Porto Alegre, Brazil

Local Institution - 0038, São Paulo, Brazil

Local Institution - 0004, Prague, Praha 5, Czechia

Revmatologicky ustav, Prague, Czechia

CHU Strasbourg-Hautepierre, Strasbourg, Alsace, France

Hopital Claude Huriez - CHU de Lille, Lille, Nord, France

Universitaetsklinikum Duesseldorf, Düsseldorf, North Rhine-Westphalia, Germany

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany

Charité - Universitaetsmedizin Berlin - Campus Bejnamin Franklin, Berlin, Germany

Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany

Local Institution - 0031, Hamburg, Germany

Sheba Medical Center, Ramat Gan, Central District, Israel

Hadassah Medical Center, Jerusalem, Israel

Uniwersyteckie Centrum Kliniczne, Gdansk, Pomeranian Voivodeship, Poland

Szpital Specjalistyczny nr 1 w Bytomiu, Bytom, Silesian Voivodeship, Poland

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy w Gliwicach, Gliwice, Silesian Voivodeship, Poland

Local Institution - 0017, Lodz, Łódź Voivodeship, Poland

ARENSIA Exploratory Medicine, Cluj-Napoca, Cluj, Romania

Fundeni Clinical Institute, Bucharest, Romania

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [Cataluña], Spain

Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad de, Spain